Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Shimada

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Vaccines|September 8, 2015
Developments in Viral Vector-Based VaccinesTakehiro Ura, Kenji Okuda, Masaru Shimada
Vaccines|September 8, 2015
Recent Developments in Preclinical DNA VaccinationKenji Okuda, Yoshiyuki Wada, Masaru Shimada
Plos One|January 26, 2012
Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promotersMasaki Shoji, Shinji Yoshizaki, Hiroyuki Mizuguchi, et al.
Vaccine|December 6, 2020
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidatesTakehiro Ura, Akio Yamashita, Nobuhisa Mizuki, et al.
Viruses|July 27, 2024
Clinical Application of Adenovirus (AdV): A Comprehensive ReviewMd Salauddin, Sukumar Saha, Md Golzar Hossain, et al.
Vaccine|July 29, 2014
Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccinationMasaru Shimada, Shinji Yoshizaki, Motohide Ichino, et al.
Gene Therapy|January 6, 2022
Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade CMasaru Shimada, Haibin Wang, Motohide Ichino, et al.
Vaccines|August 26, 2022
Current Vaccine Platforms in Enhancing T-Cell ResponseTakehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, et al.
Vaccine|June 23, 2010
DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunityMasaru Shimada, Shinji Yoshizaki, Nao Jounai, et al.
Veterinary Medicine International|November 17, 2025
Impact of Viral Diseases on the Livestock Sector in BangladeshMd Salauddin, Md Ahanaf Ajmaeen Khan, Azri Rahmati, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Vaccines|September 8, 2015
Developments in Viral Vector-Based VaccinesTakehiro Ura, Kenji Okuda, Masaru Shimada
Vaccines|September 8, 2015
Recent Developments in Preclinical DNA VaccinationKenji Okuda, Yoshiyuki Wada, Masaru Shimada
Plos One|January 26, 2012
Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promotersMasaki Shoji, Shinji Yoshizaki, Hiroyuki Mizuguchi, et al.
Vaccine|December 6, 2020
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidatesTakehiro Ura, Akio Yamashita, Nobuhisa Mizuki, et al.
Viruses|July 27, 2024
Clinical Application of Adenovirus (AdV): A Comprehensive ReviewMd Salauddin, Sukumar Saha, Md Golzar Hossain, et al.
Vaccine|July 29, 2014
Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccinationMasaru Shimada, Shinji Yoshizaki, Motohide Ichino, et al.
Gene Therapy|January 6, 2022
Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade CMasaru Shimada, Haibin Wang, Motohide Ichino, et al.
Vaccines|August 26, 2022
Current Vaccine Platforms in Enhancing T-Cell ResponseTakehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, et al.
Vaccine|June 23, 2010
DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunityMasaru Shimada, Shinji Yoshizaki, Nao Jounai, et al.
Veterinary Medicine International|November 17, 2025
Impact of Viral Diseases on the Livestock Sector in BangladeshMd Salauddin, Md Ahanaf Ajmaeen Khan, Azri Rahmati, et al.
Pageof 3